Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of ZNF300 mRNA | CTD | PMID:20660070 | 2,2',4,4'-Tetrabromodiphenyl ether | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:32653021 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of ZNF300 gene | CTD | PMID:27153756 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of ZNF300 mRNA | CTD | PMID:33212167 | arsenite(3-) | decreases expression | EXP | | 6480464 | arsenite results in decreased expression of ZNF300 mRNA | CTD | PMID:23974009 | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of ZNF300 promoter | CTD | PMID:23974009 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ZNF300 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of ZNF300 promoter | CTD | PMID:27901495 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of ZNF300 gene | CTD | PMID:31601247 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of ZNF300 mRNA | CTD | PMID:26472689 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of ZNF300 mRNA | CTD | PMID:19549813 | cyclosporin A | affects expression | EXP | | 6480464 | Cyclosporine affects the expression of ZNF300 mRNA | CTD | PMID:25562108 | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of ZNF300 gene | CTD | PMID:31601247 | methylparaben | decreases expression | EXP | | 6480464 | methylparaben results in decreased expression of ZNF300 mRNA | CTD | PMID:31745603 | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ZNF300 mRNA | CTD | PMID:27153767 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of ZNF300 mRNA | CTD | PMID:22714537 | progesterone | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of ZNF300 mRNA | CTD | PMID:20660070 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ZNF300 mRNA | CTD | PMID:34032870 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of ZNF300 mRNA | CTD | PMID:31533062 | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of ZNF300 mRNA | CTD | PMID:31758290 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of ZNF300 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZNF300 mRNA | CTD | PMID:19101580 and PMID:28001369 | |